Loading...
You are here:  Home  >  Health  >  Current News

Beijing buyers club? China’s cancer patients gamble on gray market



SHANGHAI (Reuters) - When her father's lung cancer worsened, Yin Min, a 51-year-old financial broker from Shanghai, faced a choice: pay nearly $3,000 a month for an approved drug or pay a fraction of the price for a generic drug not approved for use in China.


Other News

Thai health ministry says don’t panic over Zika virus BANGKOK (Reuters) - Thailand should not worry about the Zika virus, its public health ministry said on Tuesday, just a day after the World Health Or...
Allergan signs deal with Editas for gene-editing-based eye treatments (Reuters) - Allergan plc said on Tuesday it would get exclusive access and the option to license up to five of Editas Medicine Inc's experimental ge...
Novartis’ drug tops standard therapy in untreated lung cancer patients (Reuters) - Novartis AG said its cancer drug, Zykadia, was twice as effective as standard chemotherapy in slowing the progression of a rare form of ...

Found news:

Loading...

You might also like...

GlaxoSmithKline adult shingles vaccine wins U.S. approval

Read More →